Abstract
IntroductionCurrent pharmacological therapies in patients with type 2 diabetes (T2D) are challenged by lack of sustainability and borderline firm evidence of real long-term health benefits. Accordingly, lifestyle intervention remains the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have